New psilocybin review: it’s safe, highly effective and begs further study
To make psilocybin an FDA approved medication, there are still many hurdles to jump through. Phase 3 clinical trials need to be done to continue to show it’s safety and efficacy, and these studies are long and expensive to perform.
A recent clinical review of psilocybin, the active compound in “magic mushrooms”, shows that it holds great promise in treating psychiatric conditions such as anxiety, depression, and substance abuse. This review of seven independent studies, authored by Kelan Thomas of Toura University California and published in the peer-reviewed Journal of Psychoactive Drugs, highlights both psilocybin’s safety and its profound efficacy. Not only has psilocybin been proven to be safe to use in a clinical setting, it’s beneficial effects are far more significant and longer lasting than conventional treatments, leading many to believe it will revolutionize the field of psychiatric medicine.
Original Article (Psychedelic Times):
New Psilocybin Review: It’s Safe, Highly Effective and Begs Further Study
Artwork Fair Use: Jynto
